%0 Journal Article
%T Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
%A Byung Ho Nam
%A Hee-Jun Kim
%A In Hae Park
%A Jee Hyun Kim
%A Jin-Hee Ahn
%A Joo Hyuk Sohn
%A Jungsil Ro
%A Keun Seok Lee
%A Kyong-Hwa Park
%A Kyung Hae Jung
%A Kyung-Hun Lee
%A Seock-Ah Im
%A Suee Lee
%A Sung Hoon Sim
%A Sung-Bae Kim
%A Tae-Yong Kim
%A Yeon Hee Park
%J Archive of "Cancer Research and Treatment : Official Journal of Korean Cancer Association".
%D 2019
%R 10.4143/crt.2017.562
%K Metastatic breast cancer
%K Irinotecan
%K Capecitabine
%K Clinical trial
%K Progression free survival
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333992/